Friday 6 November 2026 Export INSM’s income statement to Excel — free account

Insmed, Inc.

INSM Healthcare Biotechnology

Insmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.4 million, up 66.7% from fiscal 2024.

Revenue: +268.4%
EPS: +73.8%
Free cash flow: +81.1%
Total debt: +0.27%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

112.52 3.76 +3.46%

Follow INSM

Alert me

Market cap: $23.9B
P/E: 0.0×
Fwd P/E: −64.6×
Dividend yield: —
F-score: 4/9
Altman Z: 9.29
Beneish M: −1.90
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Insmed, Inc. (INSM) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Insmed, Inc. (INSM) trades at a P/S ratio of 15.6×. Over the past ten years it has ranged from 0.0× (March 2019) to 100× (December 2025); the current reading is higher than 61% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/INSM/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Insmed, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/INSM/metrics/ps-ratio">Insmed, Inc. (INSM) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	57.1×	83.42%
FY2024	31.1×	126.04%
FY2023	13.8×	43.24%
FY2022	9.6×	(40.65%)
FY2021	16.2×	(18.01%)
FY2020	19.8×	33.56%
FY2019	14.8×	—
FY2018	0.0×	—

Period	P/S ratio	Change
Sep 2026	16.4×	(19.33%)
Jun 2026	20.4×	(52.62%)
Mar 2026	43.0×	(24.73%)
Dec 2025	57.1×	(16.28%)
27 more quarters	Free account

Against its own ten years

Low 0.0× High 100×

Ten-year median 12.8×

Current reading's percentile 39

Company	P/S ratio
INCY Incyte Corporation compare	4.0×
ALNY Alnylam Pharmaceuticals, Inc. compare	4.2×
EXEL Exelixis, Inc. compare	6.8×
GMAB Genmab A/S Sponsored ADR compare	7.9×
BNTX BioNTech SE Sponsored ADR compare	7.9×
ASND Ascendis Pharma A/S compare	13.5×
BBIO BridgeBio Pharma, Inc. compare	15.5×
INSM Insmed, Inc.	15.6×
ROIV Roivant Sciences Ltd. compare	3,528×
Biotechnology industry median	9.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Insmed, Inc. (INSM) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on INSM

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on INSM

Stockrow Weekly